Pharmafile Logo
Pharmafocus logo
Advanced Search

Relovair

Showing 6 posts of 6 posts found.

GSK and Theravance file COPD drug

July 16, 2012
Research and Development, Sales and Marketing EMA, GSK, Relovair, Revlar, Spiriva, Theravance

GlaxoSmithKline and US biopharma firm Theravance have submitted their investigational chronic obstructive pulmonary disease (COPD) drug to regulators in Europe …

News

Boehringer’s COPD drug passes hurdle

May 23, 2012
Research and Development, Sales and Marketing Boehringer, COPD, Daxas, Relovair, Spiriva, olodaterol

Boehringer Ingelheim’s once-daily bronchodilator olodaterol has improved lung function versus placebo in a Phase II trial.  The manufacturer wants the …

News

GSK buys more of Theravance

May 18, 2012
Research and Development, Sales and Marketing COPD, Cellzome, GSK, Relovair, Theravance

GlaxoSmithKline now owns more than a quarter of biopharma company Theravance after shelling out nearly $213 million to buy ten …

News

Underwhelming results for GSK’s Relovair

January 10, 2012
Research and Development, Sales and Marketing Advair, COPD, GSK, Relovair, Seretide, asthma

GlaxoSmithKline says it is on track to file its respiratory drug Relovair in Europe and the US despite mixed results …

News

Extra phase II studies boost GSK’s Relovair

September 23, 2010
COPD, GlaxoSmithKline, Relovair, asthma

GlaxoSmithKline has conducted additional phase II trials on its asthma/COPD drug Relovair to answer a number of safety and efficacy …

News

GSK’s Relovair moves into phase III

March 19, 2010
Research and Development GlaxoSmithKline, Relovair, Seretide, Theravance, respiratory

GlaxoSmithKline has started phase III asthma trials of Relovair, the respiratory treatment it is developing with San Francisco biopharma firm …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025